Indium (111In) imciromab
| Monoclonal antibody | |
|---|---|
| Type | Fab fragment | 
| Source | Mouse | 
| Target | cardiac myosin | 
| Clinical data | |
| Trade names | Myoscint | 
| ATC code | |
| Legal status | |
| Legal status | 
  | 
| Identifiers | |
| CAS Number | 
  | 
| ChemSpider | 
  | 
| UNII | |
|   | |
Indium (111In) imciromab (trade name Myoscint) is a mouse monoclonal antibody labelled with the radioisotope Indium-111.[1] It was used for cardiac imaging, but withdrawn in 1993.[2]
See also
References
- ^ WHO Drug Information
 - ^ "DiagnosticImaging.com: Centocor withdraws imaging agent applications". Archived from the original on 2012-02-26. Retrieved 2009-10-17.